Quarterly report pursuant to Section 13 or 15(d)

Liquidity (Details Narrative)

v3.5.0.2
Liquidity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2016
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
Net loss   $ 1,494,705 $ 1,233,327 $ 4,772,596 $ 3,886,613    
Net cash used in operating activities   (169,023)   (494,228) (1,898,677)    
Term loan and line of credit   10,000,000   $ 10,000,000      
Term loan expiration date       Sep. 01, 2019      
Line of credit facility, expiration date       Sep. 01, 2018      
Issuance of preferred stock, net of fees and expenses $ 1,300,000     $ 1,270,528      
Cash   $ 7,110,495 $ 1,613,242 7,110,495 $ 1,613,242 $ 8,039,562 $ 1,048,660
MediGain Acquisition [Member]              
Unsecured payment       5,000,000      
MediGain Acquisition [Member] | October [Member]              
Initial payment to acquire business       2,000,000      
November 2015 [Member]              
Issuance of preferred stock, net of fees and expenses       $ 4,700,000